Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-018321
Filing Date
2025-06-26
Accepted
2025-06-26 20:00:19
Documents
1
Period of Report
2025-06-24

Document Format Files

Seq Description Document Type Size
1 form4-06262025_080609.html 4  
1 form4-06262025_080609.xml 4 4136
  Complete submission text file 0001415889-25-018321.txt   5657
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Issuer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KALA PHARMACEUTICALS, INC. 490 ARSENAL WAY, SUITE 120 WATERTOWN MA 02472
Business Address
Kharabi Darius (Reporting) CIK: 0001893729 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 251081891